The report provides a comprehensive analysis of the genome editing market, focusing on technologies like CRISPR-Cas, TALEN, and ZFN. It assesses applications across biopharma, ag biotech, and research ...

MIT researchers have dramatically lowered the error rate of prime editing, a technique with promise for treating numerous genetic disorders. A genome editing method called prime editing could one day ...

The new prime editors are about as efficient as their predecessors but make up to 60-fold fewer ‘indel’ mistakes.

As CRISPR continues to drive breakthroughs in medicine, agriculture, and synthetic biology, understanding its origins does more than tell an ancient story. It provides a blueprint for engineering the ...

In what could mark a historic leap in medical science, researchers are now closer than ever to developing a CRISPR-based therapy capable of cutting the HIV virus directly out of a patient’s genome — ...

CAMBRIDGE, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today ...